BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35715944)

  • 1. Old age amyotrophic lateral sclerosis and limbic TDP-43 pathology.
    Murakami A; Koga S; Sekiya H; Oskarsson B; Boylan K; Petrucelli L; Josephs KA; Dickson DW
    Brain Pathol; 2022 Nov; 32(6):e13100. PubMed ID: 35715944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.
    Woodworth DC; Nguyen KM; Sordo L; Scambray KA; Head E; Kawas CH; Corrada MM; Nelson PT; Sajjadi SA
    Acta Neuropathol; 2024 Jun; 147(1):103. PubMed ID: 38896163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP.
    Feneberg E; Charles PD; Finelli MJ; Scott C; Kessler BM; Fischer R; Ansorge O; Gray E; Talbot K; Turner MR
    Brain Pathol; 2021 Jul; 31(4):e12923. PubMed ID: 33300249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior insula is more vulnerable than posterior insula to TDP-43 pathology in common dementias and ALS.
    Lochner RH; Arumanayagam AS; Powell SZ; Masdeu JC; Pascual B; Cykowski MD
    J Neuropathol Exp Neurol; 2024 Apr; 83(5):307-317. PubMed ID: 38591790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 in aging and Alzheimer's disease - a review.
    Wilson AC; Dugger BN; Dickson DW; Wang DS
    Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.
    Brettschneider J; Libon DJ; Toledo JB; Xie SX; McCluskey L; Elman L; Geser F; Lee VM; Grossman M; Trojanowski JQ
    Acta Neuropathol; 2012 Mar; 123(3):395-407. PubMed ID: 22210083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
    Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
    Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy.
    Koga S; Sanchez-Contreras M; Josephs KA; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Wszolek ZK; Rademakers R; Dickson DW
    Mov Disord; 2017 Feb; 32(2):246-255. PubMed ID: 28009087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old age genetically confirmed frontotemporal lobar degeneration with TDP-43 has limbic predominant TDP-43 deposition.
    Buciuc M; Whitwell JL; Baker MC; Rademakers R; Dickson DW; Josephs KA
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1050-1059. PubMed ID: 33969528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease.
    Hiya S; Maldonado-Díaz C; Walker JM; Richardson TE
    J Neuropathol Exp Neurol; 2023 Dec; 83(1):2-10. PubMed ID: 37966908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
    Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA
    Brain; 2019 Jun; 142(6):1503-1527. PubMed ID: 31039256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis.
    Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC
    Acta Neuropathol Commun; 2023 Nov; 11(1):180. PubMed ID: 37957721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroscopic Localized Subicular Thinning as a Potential Indicator of Amyotrophic Lateral Sclerosis.
    Yamada H; Takeda T; Uchihara T; Sato S; Kirimura S; Hirota Y; Kodama M; Kitagawa M; Hirokawa K; Yokota T; Toru S
    Eur Neurol; 2018; 79(3-4):200-205. PubMed ID: 29587294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain.
    Swanson MEV; Mrkela M; Murray HC; Cao MC; Turner C; Curtis MA; Faull RLM; Walker AK; Scotter EL
    Acta Neuropathol Commun; 2023 Apr; 11(1):69. PubMed ID: 37118836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease.
    Nag S; Yu L; Boyle PA; Leurgans SE; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2018 May; 6(1):33. PubMed ID: 29716643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
    Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
    Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.